Colorectal cancer, liver metastases and biotherapies

Daniel-clement Osei-bordom, Sivesh Kamarajah, Niki Christou

Research output: Contribution to journalArticlepeer-review

66 Downloads (Pure)

Abstract

(1) Background: colorectal cancer (CRC) is one of the deadliest causes of death by cancer worldwide. Its first main metastatic diffusion spreads to the liver. Different mechanisms such as the epithelial–mesenchymal transition and angiogenesis are the characteristics of this invasion. At this stage, different options are possible and still in debate, especially regarding the use of targeted therapeutics and biotherapies. (2) Methods: A review of the literature has been done focusing on the clinical management of liver metastasis of colorectal cancer and the contribution of biotherapies in this field. (3) Results: In a clinical setting, surgeons and oncologists consider liver metastasis in CRC into two groups to launch adapted therapeutics: resectable and non-resectable. Around these two entities, the combination of targeted therapies and biotherapies are of high interest and are currently tested to know in which molecular and clinical conditions they have to be applied to impact positively both on survival and quality of life of patients.
Original languageEnglish
Article number894
Number of pages18
JournalBiomedicines
Volume9
Issue number8
DOIs
Publication statusPublished - 26 Jul 2021

Keywords

  • chemotherapy and biological agents
  • colorectal cancer
  • immunotherapy
  • liver metastases

Fingerprint

Dive into the research topics of 'Colorectal cancer, liver metastases and biotherapies'. Together they form a unique fingerprint.

Cite this